Exobiosphere

Exobiosphere is a space biotech advancing drug discovery and manufacturing in microgravity, our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth.

We’re building the world’s first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems.

The goal is simple: make space a routine, essential part of the biomedical R&D pipeline so we can bring better and faster treatments to patients.